Clinical Trial

DurAVR™ THV EU-EFS

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 4, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
A prospective, non-randomized, single-arm, multi-center study designed to evaluate the safety and feasibility of DurAVR™ THV System in the treatment of subjects with symptomatic severe native aortic stenosis or failed surgical aortic bioprosthetic valves.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-07-15; most recent amendment 2026-04-28.
Status change: Not Yet Recruiting → Active, Not Recruiting 2026-04-28
Trial Details
NCT Number NCT06510855
Lead Sponsor Anteris Technologies Ltd.
Conditions Symptomatic Aortic Stenosis, Severe Aortic Valve Stenosis, Aortic Valve Calcification, Aortic Valve Failure, Aortic Valve Disease
Enrollment 40 participants
Start Date 2025-01-21
Primary Completion 2026-07 (estimated)
Study Completion 2031-08 (estimated)
Updated on ClinicalTrials.gov 2026-05-04